VGLUT2 and APP family: unraveling the neurobiochemical mechanisms of neurostimulation therapy to STZ-induced diabetes and neuropathy.

Front Endocrinol (Lausanne) · 2024 · PMC10869491 · PMID 38370359

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

an increasing trendno p-value reported

Furthermore, considering the three conditions of control, DPN, and treatment, the correlation between VGLUT2 and APP showed an increasing trend in the disease state and a decreasing trend after treatment.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.